MedAI Verdict

AI Surgical Tools

Editorial illustration: surgical instruments with an operating-room video feed translating into performance analytics.

Anatomage Table vs OTTAVA (J&J MedTech)

All comparisons
31/ 100

Anatomage Table

Competitive
35/ 100

OTTAVA (J&J MedTech)

Competitive

OTTAVA is a soft-tissue surgical robot that received FDA De Novo authorization in July 2026, record DEN250068, for ten general surgery procedures including cholecystectomy, appendectomy and gastric bypass. J&J is launching with select U.S. customers, lists no price and sells it as a capital item alongside the Polyphonic digital layer. Its authorization rested on an IDE study that began in late 2024, and analysts quoted by MedTech Dive doubt it will gain ground on Intuitive's da Vinci soon.

Anatomage's Table combines digitized cadavers, procedure simulations and DICOM scan viewing in one device. One university quoted it at $68,000, and no FDA clearance is listed for it.

The two are not substitutes. A surgical department with a robotic program is the OTTAVA buyer, and an anatomy department or simulation center is the Table's.

Surgical AI · Reviewed November 1, 2026

On this page
Anatomage Table logo

Anatomage Table

by Anatomage

Life-size touch-interactive virtual cadaver and surgical planning viz.

OTTAVA (J&J MedTech) logo

OTTAVA (J&J MedTech)

by J&J MedTech

OTTAVA, Johnson & Johnson MedTech's soft-tissue surgical robot (FDA De Novo, July 2026), with its Polyphonic digital layer.

When to pick each one

Anatomage Table

  • University quote of $68,000 for a horizontal table
  • Teaching table for anatomy departments and simulation centers
  • Imports and renders DICOM patient scans
Read the full Anatomage Table review

OTTAVA (J&J MedTech)

  • FDA De Novo authorization, DEN250068, July 2026
  • Ten general surgery procedures in the authorization
  • Polyphonic layer for learning, media and data insights
Read the full OTTAVA (J&J MedTech) review

Score

Each row shows points earned of points available under the published rubric.

Anatomage Table

31of 100Competitive

OTTAVA (J&J MedTech)

35of 100Competitive
Score by dimension for Anatomage Table and OTTAVA (J&J MedTech)
DimensionAnatomage TableOTTAVA (J&J MedTech)Difference
FDA clearance0 / 1818 / 18-18
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 1.40 / 1.40
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 0.80 / 0.80
Peer-reviewed papers14.7 / 210 / 21+14.7
RCT / meta-analysis / systematic review0 / 7.80 / 7.80
Funding & adoption signal6 / 128.4 / 12-2.4
Pricing transparency5 / 52.5 / 5+2.5
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Anatomage Table

TierMonthlyAnnualNotes
PlanFreeFree$80K-100K hardware.

OTTAVA (J&J MedTech)

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Capital sale.

Evidence

Compliance and integrations

Documented from each vendor’s own pages.

SpecAnatomage TableOTTAVA (J&J MedTech)
Free tierYesNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot statedNot stated
FoundedNot statedNot stated
HQNot statedNot stated

Scroll horizontally to see both columns.

Common questions

Open the full surgical AI comparison

Surgical video intelligence (Theator), OR analytics (OR Black Box), VR training (Osso VR, FundamentalVR), robotic AI (da Vinci 5 Case Insights). Mostly enterprise capital purchases.

See all surgical AI